Back
Invesco Oil & Gas Services ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison
Sell
46
PXJ
Invesco Oil & Gas Services ETF
Last Price:
28.23
Seasonality Move:
2.36%
Sell
16
APLS
Apellis Pharmaceuticals
Last Price:
29.47
Seasonality Move:
24.21%
Sell
46
Invesco Oil & Gas Services ETF (PXJ)
is a Sell
Is Invesco Oil & Gas Services ETF a Buy, Sell or Hold?
- The current Invesco Oil & Gas Services ETF [PXJ] share price is $28.76. The Score for PXJ is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- PXJ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
16
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $29.47. The Score for APLS is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
PXJ Stock Price Chart
What is Invesco Oil & Gas Services ETF's stock price today?
-
The Invesco Oil & Gas Services ETF share price today is $28.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PXJ is experiencing buying pressure, which is a positive indicator for future bullish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $29.47
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
PXJ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.29 | Sell |
Relative Strength Index (14 RSI): | 44.09 | Sell |
Chaikin Money Flow: | 5381 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.25 - 30.35) | Sell |
Bollinger Bands (100): | (29.64 - 32.7) | Sell |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.13 | Sell |
Relative Strength Index (14 RSI): | 27.76 | Sell |
Chaikin Money Flow: | -1016048 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.1 - 40.04) | Sell |
Bollinger Bands (100): | (35.68 - 41.62) | Sell |
PXJ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.38 | Sell |
20-day SMA: | 28.94 | Sell |
50-day SMA: | 30.25 | Sell |
200-day SMA: | 30.46 | Sell |
8-day EMA: | 29.06 | Sell |
20-day EMA: | 29.25 | Sell |
50-day EMA: | 29.96 | Sell |
200-day EMA: | 30.23 | Sell |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.28 | Sell |
20-day SMA: | 35.89 | Sell |
50-day SMA: | 36.99 | Sell |
200-day SMA: | 49.2 | Sell |
8-day EMA: | 31.93 | Sell |
20-day EMA: | 34.58 | Sell |
50-day EMA: | 36.86 | Sell |
200-day EMA: | 44.96 | Sell |
Invesco Oil & Gas Services ETF Earnings Growth & PXJ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.30 per share, and an increase next year of $1.38 per share.
Invesco Oil & Gas Services ETF Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |